[go: up one dir, main page]

AU2309692A - Method for stabilization of biomaterials - Google Patents

Method for stabilization of biomaterials

Info

Publication number
AU2309692A
AU2309692A AU23096/92A AU2309692A AU2309692A AU 2309692 A AU2309692 A AU 2309692A AU 23096/92 A AU23096/92 A AU 23096/92A AU 2309692 A AU2309692 A AU 2309692A AU 2309692 A AU2309692 A AU 2309692A
Authority
AU
Australia
Prior art keywords
biomaterials
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23096/92A
Inventor
John F Carpenter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artivion Inc
Original Assignee
Cryolife Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryolife Inc filed Critical Cryolife Inc
Publication of AU2309692A publication Critical patent/AU2309692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
AU23096/92A 1991-07-03 1992-07-02 Method for stabilization of biomaterials Abandoned AU2309692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72559391A 1991-07-03 1991-07-03
US725593 1991-07-03

Publications (1)

Publication Number Publication Date
AU2309692A true AU2309692A (en) 1993-02-11

Family

ID=24915184

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23096/92A Abandoned AU2309692A (en) 1991-07-03 1992-07-02 Method for stabilization of biomaterials

Country Status (2)

Country Link
AU (1) AU2309692A (en)
WO (1) WO1993000807A1 (en)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602023A (en) * 1992-03-24 1997-02-11 Csatary; Laszlo K. Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
US7323297B1 (en) * 1992-04-03 2008-01-29 The Regents Of The University Of California Stabilized polynucleotide complexes and methods
BE1006379A3 (en) * 1992-11-26 1994-08-09 Raymond Gilles PROCESS FOR THE PRESERVATION OF LIVING CELLS, ASSEMBLIES OF CELLS AND / OR DERIVATIVES THEREOF BY LYOPHILIZATION.
IT1256621B (en) * 1992-12-04 1995-12-12 CRYOPROTETRIC SOLUTIONS
JP3203108B2 (en) * 1993-08-26 2001-08-27 協和メデックス株式会社 Method for stabilizing glucose-6-phosphate dehydrogenase
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
DE19503685C2 (en) * 1995-01-30 2000-05-31 Invitek Gmbh Process for the preparation of complex multi-enzymatic storage-stable reaction mixtures and their use
US5556771A (en) * 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
JP2001516329A (en) * 1995-06-07 2001-09-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Stabilization of polynucleotide complex
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
IT1276684B1 (en) * 1995-06-08 1997-11-03 Bioextech Inc WATER-SOLUBLE FORMULATIONS OF STABILIZED COLLAGENASE AND PROCEDURE FOR THEIR PREPARATION
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9609779D0 (en) 1996-05-10 1996-07-17 Univ Bruxelles Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
US5962213A (en) * 1996-06-14 1999-10-05 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US6114107A (en) * 1996-06-14 2000-09-05 Biostore New Zealand Limited Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues
US5879875A (en) * 1996-06-14 1999-03-09 Biostore New Zealand Compositions and methods for the preservation of living tissues
US6037116A (en) * 1996-06-14 2000-03-14 Biostore New Zealand, Ltd. Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials
US6361933B1 (en) 1996-06-14 2002-03-26 Biostore New Zealand Limited Solutions for the preservation of tissues
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US5851985A (en) * 1996-08-16 1998-12-22 Tepic; Slobodan Treatment of tumors by arginine deprivation
EP0852951A1 (en) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stable lyophilized monoclonal or polyclonal antibodies containing pharmaceuticals
EP0868916A3 (en) 1997-03-04 2004-09-15 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active-oxygen eliminating activity
DE69829605T2 (en) * 1997-05-02 2006-02-09 Seikagaku Corp. Chondroitinase-containing compositions
IN187039B (en) 1997-12-08 2001-12-29 Council Scient Ind Res
DK1061955T3 (en) * 1998-03-13 2005-07-04 Wyeth Corp Polynucleotide composition, method of preparation and use thereof
CN100471522C (en) * 1998-03-13 2009-03-25 惠氏 Polynucleotide composition and its preparation method and use
US7276359B1 (en) 1998-03-13 2007-10-02 Wyeth Polynucleotide composition, method of preparation, and use thereof
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
DE69931166T2 (en) 1998-08-14 2007-02-15 Valentis Inc., Burlingame CO-LYOPHILIZED COMPLEX COMPRISING A NUCLEIC ACID VECTOR AND A FORMULATION AGENCY
EP0997734B1 (en) * 1998-10-29 2006-09-27 Council of Scientific and Industrial Research Composition useful for the early diagnosis of visceral leishmaniasis and a process for preparing the same
DE19850074A1 (en) * 1998-10-30 2000-05-04 Dade Behring Marburg Gmbh Stabilization of biological liquids by adding sterol esters
BR9905867A (en) * 1998-11-06 2001-01-23 Bio Sidus S A Recombinant human erythropoietin-producing cell line and the recombinant human erythropoietin produced by this cell
DK2130554T3 (en) 1999-02-22 2012-12-03 Univ Connecticut Albumin-free factor VIII preparations
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
ES2368061T3 (en) * 2000-02-08 2011-11-14 Allergan, Inc. BOTULIN TOXIN PHARMACEUTICAL COMPOSITIONS.
ES2180416B1 (en) * 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. PROCEDURE FOR THE PREPARATION OF STABILIZED REACTION MIXTURES, TOTAL OR PARTIALLY DESIRED, THAT INCLUDE, AT LEAST, ONE ENZYME, REACTION MIXES AND KITS CONTAINING THEM.
MXPA04004459A (en) * 2001-11-09 2005-05-16 Johnson & Johnson Lyophilized monoclonal antibody compositions.
WO2003055512A1 (en) 2001-12-21 2003-07-10 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
JP2004020434A (en) * 2002-06-18 2004-01-22 Canon Inc Substrate processing method
PL207018B1 (en) 2002-06-21 2010-10-29 Novo Nordisk Helth Care Ag Stabilised solid compositions of factor vii polypeptides
ES2214144B1 (en) * 2003-02-26 2005-09-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. STABILIZED COMPOSITION FOR FLUORIMETRIC, COLORIMETRIC OR CHEMIO-LUMINISCENT TESTS, KITS CONTAINING IT AND PROCEDURE FOR OBTAINING IT.
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
ATE454900T1 (en) 2003-05-23 2010-01-15 Novo Nordisk Healthcare Ag STABILIZATION OF PROTEINS IN SOLUTION
JP4658041B2 (en) 2003-06-25 2011-03-23 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Liquid composition of factor VII polypeptide
CN1568999A (en) * 2003-07-14 2005-01-26 南宁枫叶药业有限公司 Stable freeze dried formulation of spheroidine for medical use
KR100560697B1 (en) * 2003-08-06 2006-03-16 씨제이 주식회사 Erythropoietin preparations containing no albumin
KR20120104619A (en) 2003-08-14 2012-09-21 노보 노르디스크 헬스 케어 악티엔게젤샤프트 Liquid, aqueous pharmaceutical composition of factor vii polypeptides
DE10355904A1 (en) 2003-11-29 2005-06-30 Merck Patent Gmbh Solid forms of anti-EGFR antibodies
EP2311871A3 (en) * 2004-08-17 2012-08-08 Regeneron Pharmaceuticals, Inc. IL-1 antagonist stable liquid formulation
US7572893B2 (en) 2004-08-17 2009-08-11 Regeneron Pharmaceuticals, Inc. IL-1 antagonist formulations
US7655758B2 (en) 2004-08-17 2010-02-02 Regeneron Pharmaceuticals, Inc. Stable liquid IL-1 antagonist formulations
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
LT2586459T (en) 2005-03-25 2017-09-25 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations
WO2007127924A2 (en) 2006-04-28 2007-11-08 Zeltiq Aesthetics, Inc. Cryoprotectant for use with a treatment device for improved cooling of subcutaneous lipid-rich cells
HUE018715T2 (en) 2006-06-16 2024-10-28 Regeneron Pharma VEGF antagonist formulations suitable for intravitreal administration
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
GB0701253D0 (en) * 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
CA2677937A1 (en) * 2007-02-16 2008-08-21 Wyeth Use of sucrose to suppress mannitol-induced protein aggregation
EP2167686A1 (en) * 2007-06-16 2010-03-31 Enigma Diagnostics Ltd. Compositions
US8285390B2 (en) 2007-08-21 2012-10-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090081785A1 (en) 2007-09-24 2009-03-26 Hememics Biotechnologies, Inc. Desiccated Biologics And Methods Of Preparing The Same
US8815232B2 (en) 2008-08-26 2014-08-26 Kyon Biotech Ag Compositions and methods for treating cancer
ES2706296T3 (en) 2008-11-07 2019-03-28 Univ Connecticut Formulations of Factor VIII
JO3672B1 (en) 2008-12-15 2020-08-27 Regeneron Pharma High Affinity Human Antibodies to PCSK9
US20130064834A1 (en) 2008-12-15 2013-03-14 Regeneron Pharmaceuticals, Inc. Methods for treating hypercholesterolemia using antibodies to pcsk9
CA3156737A1 (en) 2009-04-30 2010-11-04 Zeltiq Aesthetics, Inc. Vacuum applicator for removing heat from subcutaneous lipid-rich cells
WO2011048227A1 (en) 2009-10-22 2011-04-28 Biotools Biotechnological & Medical Laboratories, S.A. Composition, method and kit for detecting bacteria by means of sequencing
US9943075B2 (en) * 2010-02-17 2018-04-17 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
JP5937059B2 (en) * 2010-03-22 2016-06-22 ジェネンテック， インコーポレイテッド Compositions and methods useful for stabilizing protein-containing formulations
HUE026885T2 (en) * 2010-03-31 2016-08-29 Stabilitech Ltd Stabilisation of viral particles
CN102892427A (en) 2010-03-31 2013-01-23 稳定性科技有限公司 Excipients for stabilising viral particles, polypeptides or biological material
BR112013018877A2 (en) 2011-01-28 2016-10-04 Sanofi Sa pharmaceutical compositions comprising human antibodies to pcsk9
JO3283B1 (en) 2011-04-26 2018-09-16 Sanofi Sa Composition including Afflipersept, Folinic Acid, 5- Fluorouracil (5- Fu) and Irenosetan (FOLFIRI)
AR087305A1 (en) 2011-07-28 2014-03-12 Regeneron Pharma STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES, PREPARATION METHOD AND KIT
EP2756004B1 (en) 2011-09-16 2019-12-25 Regeneron Pharmaceuticals, Inc. INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) FOR USE IN REDUCING LIPOPROTEIN(a) LEVELS
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
KR101410065B1 (en) * 2011-12-09 2014-06-27 테고사이언스 (주) Method for preserving valuable intracellular materials stably at room temperature
CN104169299B (en) 2012-01-23 2018-06-05 瑞泽恩制药公司 Stabilized preparations containing anti-Ang-2 antibody
WO2013112897A1 (en) 2012-01-27 2013-08-01 The Regents Of The University Of California Stabilization of biomolecules using sugar polymers
AR092325A1 (en) 2012-05-31 2015-04-15 Regeneron Pharma STABILIZED FORMULATIONS CONTAINING ANTI-DLL4 ANTIBODIES AND KIT
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
HK1222865A1 (en) 2013-06-07 2017-07-14 Regeneron Pharmaceuticals, Inc. Methods for inhibiting atherosclerosis by administering an inhibitor of pcsk9
CN106062003A (en) 2013-11-12 2016-10-26 赛诺菲生物技术公司 Dosing regimens for use with pcsk9 inhibitors
WO2015117032A1 (en) 2014-01-31 2015-08-06 Zeltiq Aesthestic, Inc. Treatment systems for treating glands by cooling
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
EP3157685A4 (en) 2014-06-18 2018-03-21 Luminex Corporation Methods for generating stabilized lyophilized materials
KR20230074283A (en) 2014-07-16 2023-05-26 사노피 바이오테크놀로지 METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA(heFH)
HUE043951T2 (en) 2014-07-18 2019-09-30 Sanofi Sa A procedure for predicting outcome of treatment of a cancer patient with aflibercept
WO2016076428A1 (en) 2014-11-14 2016-05-19 日本赤十字社 Method and solution for cryopreservation of umbilical cord blood and peripheral blood
CZ306818B6 (en) * 2015-01-29 2017-07-26 Masarykova Univerzita A method of suppressing freeze-induced protein denaturation when freezing and/or lyophilizing biologically active substances
ES3052976T3 (en) 2015-08-18 2026-01-16 Regeneron Pharma Anti-pcsk9 inhibitory antibodies for treating patients with hyperlipidemia undergoing lipoprotein apheresis
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
AU2019315940B2 (en) 2018-07-31 2025-05-08 Zeltiq Aesthetics, Inc. Methods, devices, and systems for improving skin characteristics
CN110699346A (en) * 2019-11-13 2020-01-17 河北省微生物研究所 Preparation method of glucose oxidase freeze-dried powder
KR20250071617A (en) * 2023-11-15 2025-05-22 (주)바이오제닉스 Stabilization complex composition for maintaining protein activity and method for producing the same
CN117705541B (en) * 2024-02-05 2024-04-26 江西赛基生物技术有限公司 Quality control product for detecting PD-1 of blood sample and preparation and quality control method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4574081A (en) * 1984-09-25 1986-03-04 Colgate-Palmolive Co. Antiplaque dentifrice having improved flavor
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
US4874690A (en) * 1988-08-26 1989-10-17 Cryopharm Corporation Lyophilization of red blood cells

Also Published As

Publication number Publication date
WO1993000807A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
AU2309692A (en) Method for stabilization of biomaterials
AU1556492A (en) Method for the stabilization of methionine-containing polypeptides
AU4257289A (en) Method for controlling the growth of cartilage
AU670143B2 (en) Method for improving the biocompatibility of solid surfaces
AU4013193A (en) Method of maintaining relationships between elements
AU3831793A (en) Spinal implant system
AU2175495A (en) System for setting ambient parameters
AU8055594A (en) Process for producing simvastatin and analogs thereof
AU4783293A (en) Method for screening compositions
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU3921993A (en) Novel antler-derived bone growth factors
AU4868493A (en) Method of combining polymers
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU1001092A (en) Process for 3-exomethylenecepham sulfoxide esters
AU1142192A (en) Process for the preparation of 13c-labelled compounds
AU3028492A (en) Process for the manufacture of 2-alkoxymethylacrolein
EP0583687A3 (en) Method for the preparation of substituted methoxyphenols and microorganisms therefore
AU4112993A (en) Temperature stabilization apparatus
AU5217693A (en) Apparatus for the manufacture of tinplates
AU2580592A (en) Method and arrangement for mechanical stabilization
AU4461493A (en) Process for the stabilization of hop products
AU8266691A (en) Method of disinfection
RU2003311C1 (en) Method of blepharorrhaphy
SG45344A1 (en) Process for the hydrocycarbonylation of lactones
AU1006892A (en) Process for the electroextraction of zinc